What’s the difference between hydrocodone bitartrate and hydrocodone?
Hydrocodone bitartrate is hydrocodone in a specific salt form. Hydrocodone by itself is often treated as the “active drug” name, while “hydrocodone bitartrate” is the pharmaceutical salt used in many immediate- or extended-release products to help with formulation and dosing consistency.
In practical terms, the pain medicine effect comes from hydrocodone itself; the “bitartrate” part is about the drug’s chemical form, not a different therapeutic drug category.
Do they have the same strength and dosing?
They can be considered equivalent only when the product label specifies the hydrocodone dose (mg of hydrocodone, not just the salt name). The salt form changes the molecular weight, so the weight of “hydrocodone bitartrate” on the label may not match the hydrocodone amount.
To compare apples-to-apples, dosing decisions should follow the medication label instructions and the clinician’s conversion guidance rather than comparing the words “bitartrate” vs “hydrocodone” alone.
Are they used in different kinds of prescriptions?
Often, yes. “Hydrocodone bitartrate” may appear as the active ingredient name on certain formulations (for example, some single-ingredient or extended-release products), while other products may list hydrocodone under different naming conventions or use combination products (such as hydrocodone with acetaminophen or other ingredients).
The key distinction for patients is not the salt name—it’s whether the product is:
- single-ingredient hydrocodone vs combination,
- immediate-release vs extended-release,
- and the total daily dose limits for both hydrocodone and any co-ingredients (like acetaminophen).
How should patients switch between products?
Patients should not switch based on the wording alone. If a prescription changes from “hydrocodone” to “hydrocodone bitartrate” (or vice versa), the prescriber/pharmacist should confirm:
- the exact product strength,
- whether it’s immediate vs extended release,
- and the correct dosing schedule and maximum daily limits.
This matters because extended-release formulations and combination products can raise overdose risk if dosed incorrectly.
What side effects and risks are the same either way?
Because hydrocodone is the active opioid, the core risks are the same whether the label says hydrocodone or hydrocodone bitartrate, including:
- sedation, dizziness, and impairment,
- respiratory depression (especially with higher doses or other sedatives),
- constipation and nausea,
- dependence and withdrawal risk with continued use,
- overdose risk if taken more frequently than prescribed.
If the product is a combination (commonly hydrocodone plus acetaminophen), acetaminophen-specific liver risk also applies.
Quick way to tell what you actually have
Check the label for:
- “mg” strength of hydrocodone (not just the salt name),
- “extended-release” vs “immediate-release,”
- and any additional ingredients (like acetaminophen).
Sources
No sources were provided with your question, so I can’t cite DrugPatentWatch.com or other references here. If you share the exact product names (or the “mg” strength and whether it’s ER/IR and whether it includes acetaminophen), I can help you compare them more precisely.